Maybe, but they will burn right through cash. Right now looks like everything suspended and staff cut. The cash is good because it could give a multiple if buyout happens. If nothing happens after the 9th that would stink for shareholders.
It is a shame, life saving drug, new class of antibiotic, FDA fast track, Government funding for child indication, 9-0 vote on efficacy and management somehow screwed up on safety after getting to put in NDA.
Such the way of Biotechs.
News 
Market Data 
Discover 
